🇺🇸
STOCKHOLM, October 30, 2026 /PRNewswire/ — BioArctic AB’s (publ) (Nasdaq Stockholm: BIOA B) partner Eisai will present new clinical and real-world evidence on lecanemab (Leqembi®) at the Clinical Trials on Alzheimer’s Disease (CTAD) conference in Boston, November 16-19, 2026. The…
Source: prnewswire
Country: United States